Disposition pharmacokinetics of bezafibrate in man
- PMID: 499297
- DOI: 10.1007/BF00644963
Disposition pharmacokinetics of bezafibrate in man
Similar articles
-
A gas chromatographic method for the determination of bezafibrate in serum and urine.J Chromatogr. 1978 Jul 21;154(2):261-3. doi: 10.1016/s0021-9673(00)98473-5. J Chromatogr. 1978. PMID: 681474 No abstract available.
-
Electrophilic reactions of acyl-linked glucuronides. Formation of clofibrate mercapturate in humans.Drug Metab Dispos. 1982 Nov-Dec;10(6):609-13. Drug Metab Dispos. 1982. PMID: 6130909
-
Steady-state kinetics of bezafibrate and clofibrate in healthy female volunteers.Eur J Clin Pharmacol. 1980 Apr;17(4):305-8. doi: 10.1007/BF00625805. Eur J Clin Pharmacol. 1980. PMID: 6995131 Clinical Trial.
-
Glucuronidation and disposition of drug glucuronides in patients with renal failure. A review.Drug Metab Dispos. 1982 Jan-Feb;10(1):87-9. Drug Metab Dispos. 1982. PMID: 6124391 Review. No abstract available.
-
[Methods of determining principal hypolipidemic agents].Therapie. 1978 Sep-Oct;33(5):587-98. Therapie. 1978. PMID: 369027 Review. French. No abstract available.
Cited by
-
Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells.PLoS One. 2017 Jun 19;12(6):e0179327. doi: 10.1371/journal.pone.0179327. eCollection 2017. PLoS One. 2017. PMID: 28628632 Free PMC article.
-
Safety of drug use in patients with a primary mitochondrial disease: An international Delphi-based consensus.J Inherit Metab Dis. 2020 Jul;43(4):800-818. doi: 10.1002/jimd.12196. Epub 2020 Feb 7. J Inherit Metab Dis. 2020. PMID: 32030781 Free PMC article.
-
Lipid lowering treatment with bezafibrate in patients on chronic haemodialysis: pharmacokinetics and effects.Klin Wochenschr. 1986 Oct 1;64(19):910-6. doi: 10.1007/BF01728614. Klin Wochenschr. 1986. PMID: 3784441
-
Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism.Mol Pharmacol. 2009 Apr;75(4):782-92. doi: 10.1124/mol.108.052928. Epub 2009 Jan 5. Mol Pharmacol. 2009. PMID: 19124612 Free PMC article.
-
Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.Drugs. 1996 Nov;52(5):725-53. doi: 10.2165/00003495-199652050-00008. Drugs. 1996. PMID: 9118820 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources